Title Collection Author Date
Stock of the Week: Moderna Stock Insight Andrew Willis 10-05-21
No Vaccine IP? No Problem! Stock Insight Karen Andersen, CFA 09-05-21
10 ESG Investments for 2021 - Part 1 ESG Investing Andrew Willis 29-04-21
Stock of the Week: Curaleaf Stock Insight Andrew Willis 22-03-21
4 Healthy Stocks for Your Portfolio Stock Insight Vikram Barhat 24-02-21
We Still Expect a Strong U.S. Economic Recovery Market Insights Preston Caldwell 09-11-20
Positive News From COVID-19 Vaccines Don't Change FVEs Stock Insight Karen Andersen, CFA 15-10-20
Contenders in the Vaccine Race Stock Insight Vikram Barhat 14-10-20
Waiting for the Cannabis Hit: 7 Stocks for Your Watchlist Stock Insight Lex Hall 29-09-20
What a Covid-19 Vaccine Means for Investors Market Insights Karen Andersen, CFA 22-07-20
Cannabis, Take Two Market Insights Andrew Willis 01-06-20
Coronavirus vaccine progress accelerates Market Insights Karen Andersen, CFA 14-05-20
2 attractive drugmakers with secure dividends Stock Insight Damien Conover, CFA 14-05-20
Is Remdesivir-maker Gilead Sciences a 'buy'? Stock Insight Karen Andersen, CFA 11-05-20
Near-term approval of Gilead's Remdesivir likely Stock Insight Karen Andersen, CFA 29-04-20
Path to a vaccine emerges as investors overreact Market Insights Karen Andersen, CFA 20-03-20
Health-care stocks: No fear of contagion Stock Insight Andrew Willis 06-02-20
The cannabis investing outlook in 5 charts Stock Insight Kristoffer Inton 17-01-20
Markets are moving on a tightrope: Manager Manager Insight Michael Ryval 07-11-19
The impact of opioid litigation on pharma stocks Video Ruth Saldanha 24-09-19
Is weed a responsible investment? Special Report Andrew Willis 10-07-19
Page   1 of 1
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies